{"id":390304,"date":"2020-12-01T07:03:15","date_gmt":"2020-12-01T12:03:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=390304"},"modified":"2020-12-01T07:03:15","modified_gmt":"2020-12-01T12:03:15","slug":"caredx-announces-first-allosure-pediatrics-publication","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/","title":{"rendered":"CareDx Announces First AlloSure Pediatrics Publication"},"content":{"rendered":"

\nCenter-run study published in Pediatric Transplantation demonstrates the utility of AlloSure for identifying allograft rejection
\n<\/h2>\n
\n

SOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the results from the first publication on the use of AlloSure in pediatric kidney transplant patients.<\/p>\n

The paper titled Donor-Derived Cell Free DNA (dd-cfDNA) for detection of Allograft Rejection in Pediatric Kidney Transplants<\/em><\/a> was published by physicians from Cedars Sinai Medical Center and the University of Texas at Houston in the journal Pediatric Transplantation. This is the first publication on dd-cfDNA for pediatric patients, demonstrating the value of AlloSure to manage this high-need population. The study included 67 patients tested between October of 2017 and October of 2019 who underwent initial testing with AlloSure as part of routine monitoring or in response to clinical suspicion for rejection.<\/p>\n

\u201cThe conclusions of our study showed that AlloSure represents a non-invasive method for early detection of rejection in pediatric renal transplants,\u201d said Dr. Dechu Puliyanda, the paper\u2019s main author. \u201cAlloSure is also highly predictive of histological rejection and superior to other indicators such as graft dysfunction or antibody positivity alone.\u201d<\/p>\n

\u201cWe are glad to support transplant centers who manage pediatric patients, where long term outcomes become even more critical as these young recipients will likely need multiple transplants throughout their lives,\u201d said Sham Dholakia, Senior Vice President, Medical Affairs and Clinical Operations for CareDx. \u201cCareDx is dedicated to transplant patient care, and this recent publication expands the evidence for broad use in clinical management.\u201d<\/p>\n

\n About<\/strong>
\n \u00a0<\/strong>
\n CareDx<\/strong>
\n
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.<\/p>\n

\n CONTACTS:<\/strong>\n <\/p>\n

CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com<\/a><\/p>\n

Investor Relations
Greg Chodaczek
646-924-1769
investor@caredx.com<\/u><\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Center-run study published in Pediatric Transplantation demonstrates the utility of AlloSure for identifying allograft rejection SOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the results from the first publication on the use of AlloSure in pediatric kidney transplant patients. The paper titled Donor-Derived Cell Free DNA (dd-cfDNA) for detection of Allograft Rejection in Pediatric Kidney Transplants was published by physicians from Cedars Sinai Medical Center and the University of Texas at Houston in the journal Pediatric Transplantation. This is the first publication on dd-cfDNA for pediatric patients, demonstrating the value of … <\/p>\n

Continue reading “CareDx Announces First AlloSure Pediatrics Publication”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-390304","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCareDx Announces First AlloSure Pediatrics Publication - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CareDx Announces First AlloSure Pediatrics Publication - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Center-run study published in Pediatric Transplantation demonstrates the utility of AlloSure for identifying allograft rejection SOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the results from the first publication on the use of AlloSure in pediatric kidney transplant patients. The paper titled Donor-Derived Cell Free DNA (dd-cfDNA) for detection of Allograft Rejection in Pediatric Kidney Transplants was published by physicians from Cedars Sinai Medical Center and the University of Texas at Houston in the journal Pediatric Transplantation. This is the first publication on dd-cfDNA for pediatric patients, demonstrating the value of … Continue reading "CareDx Announces First AlloSure Pediatrics Publication"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-01T12:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CareDx Announces First AlloSure Pediatrics Publication\",\"datePublished\":\"2020-12-01T12:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/\"},\"wordCount\":366,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/\",\"name\":\"CareDx Announces First AlloSure Pediatrics Publication - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=\",\"datePublished\":\"2020-12-01T12:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-first-allosure-pediatrics-publication\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CareDx Announces First AlloSure Pediatrics Publication\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CareDx Announces First AlloSure Pediatrics Publication - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/","og_locale":"en_US","og_type":"article","og_title":"CareDx Announces First AlloSure Pediatrics Publication - Market Newsdesk","og_description":"Center-run study published in Pediatric Transplantation demonstrates the utility of AlloSure for identifying allograft rejection SOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the results from the first publication on the use of AlloSure in pediatric kidney transplant patients. The paper titled Donor-Derived Cell Free DNA (dd-cfDNA) for detection of Allograft Rejection in Pediatric Kidney Transplants was published by physicians from Cedars Sinai Medical Center and the University of Texas at Houston in the journal Pediatric Transplantation. This is the first publication on dd-cfDNA for pediatric patients, demonstrating the value of … Continue reading \"CareDx Announces First AlloSure Pediatrics Publication\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-01T12:03:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CareDx Announces First AlloSure Pediatrics Publication","datePublished":"2020-12-01T12:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/"},"wordCount":366,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/","name":"CareDx Announces First AlloSure Pediatrics Publication - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=","datePublished":"2020-12-01T12:03:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDQ4NiMzODUwMTkwIzIwMDQ1MDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-first-allosure-pediatrics-publication\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CareDx Announces First AlloSure Pediatrics Publication"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=390304"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390304\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=390304"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=390304"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=390304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}